International patterns and trends in ovarian cancer incidence, overall and by histologic subtype

S.B. Coburn,F. Bray,M.E. Sherman,B. Trabert
DOI: https://doi.org/10.1002/ijc.30676
2017-03-21
International Journal of Cancer
Abstract:Internationally, ovarian cancer is the 7th leading cancer diagnosis and 8th leading cause of cancer mortality among women. Ovarian cancer incidence varies by region, particularly when comparing high vs. low-income countries. Temporal changes in reproductive factors coupled with shifts in diagnostic criteria may have influenced incidence trends of ovarian cancer and relative rates by histologic subtype. Accordingly, we evaluated trends in ovarian cancer incidence overall (1973-1977 to 2003-2007) and by histologic subtype (1988-1992 to 2003-2007) using volumes IV-IX of the Cancer Incidence in Five Continents database (CI5plus) and CI5X (volume X) database. Annual percent changes were calculated for ovarian cancer incidence trends, and rates of histologic subtypes for individual countries were compared to overall international incidence. Ovarian cancer incidence rates were stable across regions, although there were notable increases in Eastern/Southern Europe (e.g., Poland: Annual Percent Change (APC) 1.6%, p = 0.02) and Asia (e.g., Japan: APC 1.7%, p = 0.01) and decreases in Northern Europe (e.g., Denmark: APC -0.7%, p = 0.01) and North America (e.g., US Whites: APC -0.9%, p < 0.01). Relative proportions of histologic subtypes were similar across countries, except for Asian nations, where clear cell and endometrioid carcinomas comprised a higher proportion of the rate and serous carcinomas comprised a lower proportion of the rate than the worldwide distribution. Geographic variation in temporal trends of ovarian cancer incidence and differences in the distribution of histologic subtype may be partially explained by reproductive and genetic factors. Thus, histology-specific ovarian cancer should continue to be monitored to further understand the etiology of this neoplasm.
oncology
What problem does this paper attempt to address?
The problems that this paper attempts to solve are: to analyze the changing trends of ovarian cancer incidence worldwide and its distribution according to histological subtypes. Specifically, by studying the changes in ovarian cancer incidence in different countries and regions from 1973 to 2007, the author explored the following aspects: 1. **Trends in global ovarian cancer incidence**: - To study whether there have been significant changes in ovarian cancer incidence worldwide. - To explore the changing trends of ovarian cancer incidence in different regions (such as Eastern Europe, Southern Europe, Asia, Northern Europe, and North America). 2. **Analysis of ovarian cancer incidence by histological subtypes**: - To analyze the incidence changes of different histological subtypes (such as serous carcinoma, mucinous carcinoma, endometrioid carcinoma, clear - cell carcinoma, etc.). - To compare the distribution differences of these subtypes between different countries and regions. 3. **Explanation of geographical and temporal differences**: - To explore the potential factors causing changes in ovarian cancer incidence in different regions, including reproductive, behavioral, lifestyle, and genetic factors. - To pay special attention to the reasons for the relatively high proportions of certain subtypes (such as clear - cell carcinoma and endometrioid carcinoma) in Asian countries. ### Main findings - **Global trends**: Overall, the global ovarian cancer incidence has remained relatively stable, but it has increased in parts of Eastern Europe, Southern Europe, and Asia, while it has decreased in Northern Europe and North America. - **Regional differences**: For example, the ovarian cancer incidence in Poland and Japan has increased significantly, while the incidence in Denmark and white Americans has decreased. - **Distribution of histological subtypes**: Ovarian cancer is mainly serous carcinoma in most countries, but in Asian countries, the proportions of clear - cell carcinoma and endometrioid carcinoma are relatively high, while the proportion of serous carcinoma is relatively low. - **Potential influencing factors**: The study points out that the use of oral contraceptives, parity, post - menopausal hormone therapy, and genetic factors (such as BRCA1 and BRCA2 gene mutations) may partly explain these differences. Through these analyses, the author hopes to better understand the etiology of ovarian cancer and provide a scientific basis for future prevention and treatment.